LONDON/ZURICH (Reuters) – Swiss food group Nestle accelerated a push into the fast-growing skincare market on Wednesday, buying the rights to several injectable treatments for facial wrinkles and lines from Valeant Pharmaceuticals International for $1.4 billion.
The world’s...
Nestle boosts skincare business with $1.4 billion Valeant deal
Wednesday, May 28, 2014
Nestle boosts skincare business with $1.4 billion Valeant deal
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment